Aspirin can prevent heart attacks after noncardiac surgery in patients with prior PCI

November 14, 2017
Graham found that aspirin can help prevent heart attacks in non-cardiac surgery patients who previously had a coronary procedure such as an angioplasty or stent. Credit: Melissa Fabrizio

A Canadian-led study has found that perioperative aspirin can prevent heart-related complications after major noncardiac surgery in patients with previous percutaneous coronary intervention (PCI) such as an angioplasty or stent.

The study found that for every 1,000 with PCI, giving them at the time of would prevent 59 heart attacks and cause eight major bleeding events. The results of this study are significant, given that 200 million adults undergo major noncardiac surgery annually.

These results were a substudy of POISE-2, a large international study with sites in 135 centres in 23 countries, including Edmonton. Patients with previous PCI were enrolled in 82 centres in 21 countries.

Noncardiac surgeries occur daily at hospitals around the world, so the study results will have a big impact on this patient group.

"This is your next-door neighbour who had angioplasty five years ago, feels fine and needs to go in for hip surgery. It affects quite a large number of people," said Michelle Graham, an interventional cardiologist, professor in the University of Alberta's Department of Medicine and lead of the substudy. "We believe that perioperative aspirin in this group of patients will most likely benefit them and reduce their risk of serious vascular complications."

In patients without a PCI, POISE-2 found that aspirin did not reduce the risk of heart attack and led to an increased risk of major bleeding.

Of the 10,010 participants enrolled in the POISE-2, 470 had a previous PCI. Since patients with a prior PCI have an increased risk of cardiovascular complications after noncardiac surgery, the group wanted to see if the findings were the same in the subgroup.

This was the largest randomized trial of patients with PCI undergoing major noncardiac surgery. Although the study found that aspirin reduced the risk of , it did slightly increase the risk of bleeding, though it did not appear worse than in the overall POISE-2 trial.

"There will be a big knowledge translation push with our colleagues in anesthesia and to remind them we want them to continue aspirin in this group of patients, when for most other groups we're recommending they stop," says Graham.

The Canadian Cardiovascular Society guidelines published last year indicated that aspirin should not be given in the perioperative period.

"This will potentially change the practice of anyone who does perioperative medicine," said Graham.

Graham recognizes that studies like this are not possible without the participation of patients.

"We could not advance the field of medicine without the patients that participate in trials like POISE-2," said Graham. "This really is a team sport, we need the surgeons, anesthesiologist and patients on board to make it successful."

The study 'Aspirin in Patients with Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery' was published in Annals of Internal Medicine on November 14, 2017.

Explore further: Rate of death, heart attack after noncardiac surgery decreases, although risk of stroke increases

More information: Annals of Internal Medicine (2017). DOI: 10.7326/M17-2341

Related Stories

Rate of death, heart attack after noncardiac surgery decreases, although risk of stroke increases

December 28, 2016
In a study published online by JAMA Cardiology, Sripal Bangalore, M.D., M.H.A., of the New York University School of Medicine, New York, and colleagues examined national trends in perioperative cardiovascular outcomes and ...

Major bleeds rise with perioperative aspirin for non-cardiac surgery

March 31, 2014
Patients given aspirin to prevent heart problems after non-heart-related surgery had a higher risk of serious bleeding than the patients who did not receive aspirin. At the same time, aspirin did not reduce incidence of post-operative ...

Elevated biomarker following surgery linked to increased risk of death

April 25, 2017
Among patients undergoing noncardiac surgery, peak postoperative high-sensitivity troponin T measurements (proteins that are released when the heart muscle has been damaged) during the first three days after surgery were ...

Aspirin before non-cardiac surgery is ineffective and often harmful

April 9, 2014
(Medical Xpress)—Queen's University and Kingston General Hospital researchers are part of a groundbreaking international study that has shown that starting – or continuing – to take Aspirin before non-cardiac surgery ...

Aspirin or blood pressure medication before and after surgery does not reduce risk of AKI

November 15, 2014
In patients undergoing noncardiac surgery, neither aspirin nor clonidine (a medication primarily used to treat high blood pressure) taken before and after surgery reduced the risk of acute kidney injury, according to a study ...

Research reveals aspirin is safe for heart surgery patients

February 25, 2016
A worldwide study led by Monash University clinician-researchers shows that patients who take aspirin before heart surgery are at no greater risk of bleeding or complications. 

Recommended for you

Some cancer therapies may provide a new way to treat high blood pressure

November 20, 2017
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators. The finding could offer a real advance in hypertension treatment ...

Could this protein protect people against coronary artery disease?

November 17, 2017
The buildup of plaque in the heart's arteries is an unfortunate part of aging. But by studying the genetic makeup of people who maintain clear arteries into old age, researchers led by UNC's Jonathan Schisler, PhD, have identified ...

Raising 'good' cholesterol fails to protect against heart disease

November 16, 2017
Raising so-called 'good' cholesterol by blocking a key protein involved in its metabolism does not protect against heart disease or stroke, according to a large genetic study of 150,000 Chinese adults published in the journal ...

Popular e-cigarette liquid flavorings may change, damage heart muscle cells

November 16, 2017
Chemicals used to make some popular e-cigarette liquid flavorings—including cinnamon, clove, citrus and floral—may cause changes or damage to heart muscle cells, new research indicates.

New model estimates odds of events that trigger sudden cardiac death

November 16, 2017
A new computational model of heart tissue allows researchers to estimate the probability of rare heartbeat irregularities that can cause sudden cardiac death. The model, developed by Mark Walker and colleagues from Johns ...

Possible use for botulinum toxin to treat atrial fibrillation

November 16, 2017
From temporarily softening wrinkles to easing migraines, botulinum toxin has become a versatile medical remedy because of its ability to block nerve signals that can become bothersome or risky.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.